Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab

Fig. 2

Mean Change in Central Retinal Thickness Measured by Optical Coherence Tomography for the Selected Eye. After the initial 3 loading doses, there is a gradual worsening of macular edema between weeks 8 and 16, suggesting under-treatment during this period. n: Number of patients with available recordings of CRT

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us